...
首页> 外文期刊>癌と化学療法 >A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma
【24h】

A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma

机译:肝动脉内灌注丝裂霉素C与可降解淀粉微球治疗乙状结肠癌肝转移的一例报道

获取原文
获取原文并翻译 | 示例

摘要

A 46-year-old man underwent polypectomy of sigmoid colon in January 1996. The adenocarcinoma invaded the submucosal layer, and sigmoidectomy and D2 lymph node dissection were performed one month later. Follow-up CT revealed liver metastases, and partial hepatectomy was performed in January 1998. Afterward, weekly high dose intra-hepatic arterial chemotherapy (5-FU: 1,000 mg/body) was performed 41 times, but CT revealed multiple liver metastases in October 1998. Therefore, intra-hepatic arterial infusion of mitomycin C (MMC) with degradable starch microspheres (DSM) was given in November 1998. As follow-up CT revealed that the liver metastases were growing, partial hepatectomy was performed again in March 1999. No carcinoma was seen in the resected liver. After the second hepatectomy, intra-hepatic arterial infusion of MMC with DSM was performed five times. No evidence of recurrence has been seen. Intra-hepatic arterial infusion of MMC with DSM is recommended for liver metastases of colorectal cancer asa second line treatment.
机译:1996年1月,一名46岁的男子接受了乙状结肠息肉切除术。腺癌侵犯了黏膜下层,一个月后进行了乙状结肠切除术和D2淋巴结清扫术。随访CT显示有肝转移,并于1998年1月进行了部分肝切除术。随后,每周进行大剂量肝内动脉化疗(5-FU:1,000 mg /人),进行了41次,但CT显示在10月有多处肝转移。 1998年。因此,1998年11月进行了肝动脉内丝裂霉素C(MMC)与可降解淀粉微球(DSM)的输注。由于后续CT显示肝转移正在发展,1999年3月再次进行了部分肝切除术。在切除的肝脏中未见癌变。第二次肝切除术后,MMC与DSM进行肝内动脉输注五次。没有发现复发的证据。建议将MMC与DSM的肝内动脉输注用于结直肠癌的肝转移,作为第二线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号